Article | Open

Bifidobacteria exhibit social behavior through carbohydrate resource sharing in the gut

  • Scientific Reports 5, Article number: 15782 (2015)
  • doi:10.1038/srep15782
  • Download Citation
Received:
Accepted:
Published online:

Abstract

Bifidobacteria are common and frequently dominant members of the gut microbiota of many animals, including mammals and insects. Carbohydrates are considered key carbon sources for the gut microbiota, imposing strong selective pressure on the complex microbial consortium of the gut. Despite its importance, the genetic traits that facilitate carbohydrate utilization by gut microbiota members are still poorly characterized. Here, genome analyses of 47 representative Bifidobacterium (sub)species revealed the genes predicted to be required for the degradation and internalization of a wide range of carbohydrates, outnumbering those found in many other gut microbiota members. The glycan-degrading abilities of bifidobacteria are believed to reflect available carbon sources in the mammalian gut. Furthermore, transcriptome profiling of bifidobacterial genomes supported the involvement of various chromosomal loci in glycan metabolism. The widespread occurrence of bifidobacterial saccharolytic features is in line with metagenomic and metatranscriptomic datasets obtained from human adult/infant faecal samples, thereby supporting the notion that bifidobacteria expand the human glycobiome. This study also underscores the hypothesis of saccharidic resource sharing among bifidobacteria through species-specific metabolic specialization and cross feeding, thereby forging trophic relationships between members of the gut microbiota.

Introduction

Bifidobacteria are Gram positive bacteria with high GC-content genomes that typically reside in the gastro intestinal (GIT) tract of various animal species, including warm blooded mammals and social insects1,2. Noteworthy, bifidobacteria reach a very high relative abundance as part of the infant gut microbiota3,4,5, and this early life prevalence supports their purported role as modulators of various metabolic and immune activities of their host1. Non-digestible carbohydrates derived from the diet, together with host-produced glycans found in the mammalian gut represent critical energy sources believed to be responsible for the survival and proliferation of many microbial components of the gut microbiota, including bifidobacteria6. It is therefore important to know what molecular strategies are employed by members of the gut microbiota to harvest and metabolize complex glycans in order to understand how they underpin their ecological fitness in, and adaptation to, the GIT environment. Furthermore, carbohydrate metabolism in the mammalian gut may occur in a concerted manner by various members of the microbiota, including bifidobacteria7. Thus, carbohydrates are presumed to be partly responsible for microbiota dynamics in this changeable environment. Genomics has been crucial in revealing the complex interactions and molecular dialogue between a host and its resident (bifido)bacteria, and in unraveling bifidobacterial gut colonization strategies8. Recently, all 47 currently recognized bifidobacterial sub/species have been genomically decoded9,10, thus providing the necessary genetic background for this group of bacteria. Here, we describe an analysis of the genomes and transcriptomes of representatives of all 47 (sub)species that are currently assigned to the Bifidobacterium genus, predicting bifidobacterial genome-based strategies for carbohydrate metabolism that impact on the overall glycobiome of the gut microbiota and host, while also being pivotal for the establishment of trophic relationships between members of gut microbiota.

Results and Discussion

Genomes of the Bifidobacterium genus and carbohydrate metabolism

Genome sequences from the type strain of each of the 47 Bifidobacterium (sub)species (Table S1) were used to assess the contribution of carbohydrate metabolism to the corresponding pan-genome, core genome and variome, determined as described previously9. In total, 18,181 and 551 BifCOGs (Bifidobacterium-specific Clusters of Orthologous Genes) represent the pan-genome (pan BifCOGs) and the core of bifidobacterial genomic coding sequences (core BifCOGs) of the Bifidobacterium genus, respectively. Functional annotation of the core BifCOGs, based on a recently updated EggNog database11, indicates, as expected, that a large part of the conserved core genes encode housekeeping functions and functions involved in the adaptation to/interaction with a particular environment, including carbohydrate metabolism (Fig. S1). Interestingly, about 5.5% of the core BifCOGs is associated with carbohydrate metabolism (Fig. S1), whereas the carbohydrate metabolism functional family is the most represented COG family of the pan BifCOGs (13.7%) (Fig. S1). This finding suggests a strong selective pressure towards the acquisition and retention of accessory genes for carbohydrate utilization by bifidobacteria in order to be competitive in a particular ecological niche. The commitment of bifidobacteria towards the utilization of a wide array of simple and complex carbohydrates is further underlined by EggNog profiling of adult human’s faecal metagenomes sequenced as part of the Human Microbiome Project (HMP). Results showed that the average abundance of the carbohydrate metabolism functional family in HMP metagenomic datasets is 8.0%, thus being 58% lower than the abundance detected in the bifidobacterial pan-genome, i.e. 13.7% (Fig. S1). Notably, the carbohydrate metabolism functional family is the most abundantly represented COG family within the Bifidobacterium pan-genome (Fig. S1). The pan-genome analysis also allowed the identification of the Truly Unique Genes (TUG), consisting of genes present in just one of the examined bifidobacterial genomes (Fig. S1). Interestingly, no functional annotation can be made for the majority of TUGs (54.1%) (Fig. S1). However, 13.2% of the identified TUG can be attributed to a COG family representing proteins involved in carbohydrate metabolism, including glycosyl hydrolases (GH) and carriers for carbohydrate uptake. This data supports the notion that carbohydrate metabolism supports adaptation and specialisation processes, and consequently speciation within the Bifidobacterium genus.

Carbohydrate-active enzymes encoded by the genus Bifidobacterium

Considering the importance of carbohydrate metabolism and energy conversion systems in gut inhabitants such as bifidobacteria, we decided to investigate the presence of genes predicted to encode GHs, polysaccharide lyases (PLs), carbohydrate esterases (CE), glycosyl transferases (GT) and carbohydrate binding modules (CBM), and other carbohydrate metabolic pathway components using the predicted core- and pan-genome of the Bifidobacterium genus. Genomic data showed that B. scardovii and B. biavatii have a significantly larger set of genes involved in carbohydrate metabolism, also termed glycobiome12, as compared to other bifidobacterial species (Fig. 1). Normalization of GH counts against genome size (Mbp), generating a GH index, provided an insight into the relative extent of adaptive events related to carbohydrate metabolism found in individual bifidobacterial species. Notably, four species (B. scardovii, B. biavatii, Bifidobacterium saeculare and Bifidobacterium dentium) possess a GH index that is approximately 50% higher than the bifidobacterial average (Fig. 1). Classification according to the Carbohydrate Active Enzymes (CAZy) system13 revealed that the pan-genome of the analysed Bifidobacterium representatives includes 3,385 genes encoding predicted carbohydrate-active enzymes, including members of 57 GH, 13 GT and seven CE families (Fig. 1, Fig. S2 and Fig. S3), while no putative Polysaccharide Lyases (PL)-encoding genes were detected. Genes encoding members of CAZy family GH13 are most commonly found in bifidobacterial genomes, especially for those bifidobacteria isolated from the mammalian gut (24.2% of the total predicted bifidobacterial GH repertoire, Fig. 1). Enzymes belonging to this family are widespread in bacteria and are characterized by their degradative abilities towards a wide range of carbohydrates, including plant-derived polysaccharides, such as starch and related substrates (amylose and amylopectin and/or (cyclo)maltodextrins), and trehalose. Furthermore, stachyose, raffinose and melibiose may also represent a target for members of the GH13 family14 and their complete breakdown is achieved with the involvement of GH36 enzymes, which were shown to be abundant in the analysed bifidobacterial genomes (Figure S2). Such carbon sources indeed represent very common glycans found in the adult mammalian (omnivore and herbivore) diet6. We also observed distinct differences between predicted glycobiomes of Bifidobacterium species with regards to their (predicted) ability to degrade plant polysaccharides as opposed to host-derived glycans, such as N- or O-linked glycoproteins, human milk oligosaccharides (HMOs) and glycosaminoglycans1. The bifidobacterial glycobiome was shown to contain members of GH families that are known to be involved in host-glycan degradation, such as GH33, encompassing exo-sialidases, GH29 and GH95, which represent fucosidases, GH20, which include hexosaminidase and lacto-N-biosidase activities, GH112, representing lacto-N-biosidases, GH38 and GH125, involving α-mannosidases as well as GH101 and GH129, which include α-N-acetylgalactosaminidases. Interestingly, members of the B. scardovii, B. longum subsp. infantis and Bifidobacterium bifidum species possess the most extensive set of such host-glycan-degrading GH families (Fig. 1). Such glycobiome specialization probably reflects species-specific adaptation to a particular ecological niche and illustrates strict co-evolution with their mammalian host. Clustering of bifidobacterial species based on their predicted GH and carbohydrate-degradation pathway repertoire (Fig. 1) allows the identification of a cluster, designated as GHP/A, representing species with a considerable array of predicted GH43 family enzymes involved in degradation of complex plant polysaccharides, such as (arabino)xylan, which plays an important structural role as a main constituent of the plant cell wall15, and as such represents a substantial component of plant cell wall-derived dietary fiber16. This finding suggests that bifidobacteria rich in GH43 member-specifyings genes are adapted to hosts with a vegetarian or omnivore diet. A subgroup of the cluster GHP/A, named GHP/A1, appears to possess a wider array of GHs (Fig. 1). This subgroup encodes a large number of GH3 family enzymes that are predicted to be involved in the degradation of an extensive range of plant-derived polysaccharides (e.g., cellodextrin, (arabino)xylan and (arabino)galactan), as well as involved in bacterial cell wall biosynthesis and turnover. Notably, bifidobacterial species isolated from honey/bumblebees specify a peculiar GHP/C cluster, whose members possess a discrete set of GH43 and GH3 enzymes, but in addition these particular bifidobacterial genomes are predicted to encode a very limited repertoire of GH13 representatives, in contrast to all other bifidobacteria. This is in accordance with the absence or paucity of carbohydrates with α-glucosidic linkages in the honey/bumblebee diet17. The remaining bifidobacterial species, not fitting in clusters GHP/A or GHP/C, are included in cluster GHP/B, which is characterized by an under-representation of GH43 and GH3.

Figure 1: Predicted glycobiome of the Bifidobacterium genus and some additional members of the Bifidobacteriaceae family.
Figure 1

GH families and carbohydrate-utilization pathways profiles, based on CAZy database and Pathway-tools software, respectively, were used to construct a hierarchical clustering of all tested species of the Bifidobacteriumgenus and additional members of the Bifidobacteriaceae family. This clustering highlights the presence of three distinct clusters named GHP/A, GHP/B and GHP/C that display a different repertoire of GHs as well as a different repertoire of plant carbohydrate degradation pathways. GH arsenal prediction for every analyzed Bifidobacteriaceae species is represented by a bar plot. The presence of pathways for degradation of simple or complex carbohydrates is represented by the red color in the heat map and the GH index (the number of GHs predicted in each genome normalized by genome size expressed as Mbp) is illustrated as an orange bar plot. Pathways denominations are indicated as follows: 1 Bifidobacteriumshunt, 2 galactose degradation I (Leloir pathway), 3 melibiose degradation, 4 ribose degradation, 5 lactose degradation III, 6 glycogen degradation I, 7 glycogen degradation II, 8 sucrose degradation IV, 9 L-arabinose degradation I, 10 xylose degradation I, 11 D-mannose degradation, 12 (1,4)-ß-xylan degradation, 13 starch degradation V, 14 chitin degradation (chitinase), 15 trehalose degradation IV, 16 Pectin (homogalacturonan) degradation, 17 2'-deoxy-a-D-ribose 1-phosphate degradation, 18 trehalose degradation I (low osmolarity), 19 L-rhamnose degradation II.

In order to further evaluate the importance of the bifidobacterial contribution to degradation of complex carbohydrates found in the human gut, we compared the bifidobacterial GH repertoire with all the so far sequenced members of the human gut microbiome18,19. For this purpose, we used GH data of 2,674 genomes available in the CAZy database13 with the addition of data obtained from the bifidobacterial genomes analysed in this study. Interestingly, the Bifidobacterium genus was shown to specify one of the largest arsenal of GH13, GH43, GH3 and GH51 family members (2.0 fold-, 2.6 fold-, 5.8 fold-, 7.0 fold-, respectively, more with respect to the average GH arsenal of the gut microbiome), along with Bacteroides spp. (Bacteroidales family) and Clostridiales family. Furthermore, abundance of these GH families has been shown by a small number of other members of the gut microbiota such as Paenibacillus spp. (Bacillales family) and Streptomyces spp. (Actinomycetales family) (Fig. 2). These findings corroborate the very substantial contribution to glycan-breakdown potential by bifidobacteria in the mammalian gut.

Figure 2: Comparative analysis of bifidobacterial GHs against other gut bacteria.
Figure 2

The central heat map shows GH prediction data of 2721 sequenced bacterial strains belonging to bacterial orders residing in the human gut, identified by different color codes as explained in the underlying table. The four heat map rows, situated above the main heat map, represent an enlarged view of the GH51, GH3, GH43 and GH13 content. Data regarding Bifidobacteriales are highlighted in blue. Data regarding Clostridiales and Bacteroidales are highlighted in green.

Secreted glycosyl hydrolases of bifidobacteria

In order to allow GH enzymes produced by different organisms to act in concert and to access glycans with a degree of polymerization exceeding that of the corresponding uptake system, certain GH enzymes are expected to be located on the cell surface or secreted into the environment. Notably, even though the majority of the identified GH enzymes from the bifidobacterial pan-genome is predicted to be intracellular, 10.9% of the deduced bifidobacterial GH pool is predicted to be extracellular, of which 32.9% are members of the GH13 family and annotated as pullulanases and α-amylases, 24% are members of the GH43 family and predicted to act as β-xylosidases and α-L-arabinofuranosidases, while 12% are members of the GH51 family and classified as α-L-arabinofuranosidases. These data suggest that bifidobacteria secrete a relevant pool of GH for the degradation of plant polysaccharides, which would accordingly represent an important resource for the host in the context of obtaining access to dietary fibres. The secreted bifidobacterial pan-genome also encompasses GHs involved in host-glycan degradation (see above), being classified as families GH29, GH33, GH95 and GH101, and constituting 0.4%, 3.5%, 0.8% and 2.7% of this secreted pan-genome, respectively. Predicted extracellular GHs were identified in 43 species of the genus Bifidobacterium, with a particularly high prevalence in B. biavatii (endowed with 17 secreted GHs, including 4 GH43 and 4 GH13 members), B. scardovii (endowed with 11 secreted GHs, including 3 GH43 and 3 GH51, annotated as α-L-arabinofuranosidases) and B. bifidum (endowed with 11 secreted GHs, including two GH84 and two GH33 members, predicted to act as N-acetyl β-glucosaminidases and sialidases, respectively). The remaining bifidobacterial genomes are predicted to encode seven or less secreted GHs. The two secreted N-acetyl β-glucosaminidases and the two secreted sialidases found in B. bifidum are crucial for the utilization of HMOs and intestinal glycoconjugates such as mucin, thus further supporting the notion that this microorganism is highly adaptated to colonize and persist in the mammalian gut20,21. Nevertheless, B. bifidum is unable to use sialic acid as its sole carbon source and the activity of sialidases appears to be important only to allow access to other carbohydrates associated to sialylated host-encoded glycans20,21. Furthermore, the released sialic acid can be utilized by other bifidobacteria, such as B. breve, resulting in cross-feeding between bifidobacterial species that share the same ecological niche20,21.

Saccharolytic pathways of bifidobacteria

Predictions of complete pathways for the degradation of simple (di/trisaccharides) and complex sugars through Pathway Tools software22 showed that B. biavatii specifies the largest number of such pathways (14 complete pathways) (Fig. 1), while the predicted repertoire for carbohydrate degradation of B. bombi, Bifidobacterium crudilactis, B. longum subsp. infantis, B. minimum and Bifidobacterium ruminantium is limited to just nine pathways (Fig. 1). Notably, when assessing presence/absence data of pathways involved in the breakdown of simple and complex carbohydrates shown in the GHP clustering profile (Fig. 1), bifidobacterial species isolated from honey/bumblebees, constituting cluster GHP/C (Fig. 1), lack genes encoding glycogen degradation I and glycogen degradation II pathways. Based on recent discoveries, glycogen metabolic pathways are present in bacterial species able to face diverse environments and showing a flexible lifestyle23. More recently, it was reported that the ability of Lactobacillus acidophilus to synthesize and store energy in the form of glycogen, either prior to or during its transit through the host, potentially confers a competitive advantage in the GI tract24. This is supported by the fact that glycogen storage is ubiquitous among enteric bacteria, possibly due to the necessity to support rapid growth in the intestinal environment where there is intense trophic competition25. On the other hand, it was hypothesized26 that the loss of glycogen pathways is a strong indication of genome degradation associated with parasitic or symbiotic behaviour of bacteria. Though the original study of Henrissat et al. was based on the analysis and comparison of just 55 fully sequenced bacterial genomes, their findings have more recently been substantiated by others involving 1202 bacterial proteomes23. Among Bifidobacteriaceae, it is noteworthy that B. actinocoloniiforme, B. asteroides, B. bohemicum, B. bombi, B. coryneforme and B. indicum, species isolated from insects and constituting the GHP/C cluster, show a smaller genome size compared to all other bifidobacterial species isolated from mammals. We therefore speculate that Bifidobacterium members linked to insects have enjoyed a longer adaptation history to their hosts, in evolutionary terms, because mammals appeared on earth in the late Paleocene (between 65 and 23 mya), whereas insects in the Devonian period (between 459 and 359 mya) or even before according to a recent phylogenomics study27. This hypothesis is confirmed by comparison of the phylogenetic supertree of all known bifidobacterial species and that obtained for their corresponding hosts, revealing a co-evolution host-microbe profile (Fig. S4).

The genomes of B. asteroides, B. actinocoloniiforme, B. indicum, B. coryneforme, B. bombi and B. bohemicum possess a complete trehalose degradation IV pathway, which is absent in the majority of the other bifidobacteria and in all other examined members of the family Bifidobacteriaceae. The acquisition of this pathway, which is apparently specific for bifidobacterial species isolated from the insect gut, may be related to the fact that trehalose is used as carbohydrate storage and blood-sugar by many insects including bees28. Remarkably, a large majority of bifidobacterial genomes included in cluster GHP/B do not encompass pathways for L-arabinose and/or xylose metabolism (Fig. 1). These genomes encode relatively few GH43 enzymes compared to the GHP/A and GHP/C clusters, thus confirming a strict genetic adaptation to ecological niches where these plant carbohydrates are not available. The ecological origin of most of the GHP/B members that do not possess L-arabinose and/or xylose degradation pathways is either raw/fermented milk or faecal material/gastrointestinal tract of suckling animals (Table S1), where a milk-based diet represents the main nutrient retrieval opportunity. In this context, B. breve, B. bifidum and B. longum subsp. infantis have been isolated from infants, B. thermacidophilum subsp. porcinum and B. choerinum from piglet, B. crudilactis from raw bovine milk and B. mongoliense from fermented mare’s milk (Table S1), thus suggesting that these species have evolved to focus solely or predominantly on the degradation of carbon sources present in milk and have lost or did not acquire the ability to use (certain) plant polysaccharides. Fermented milk is a strict anthropogenic environment and these bacteria are unlikely to have evolved in fermented milk per se. In fact, the natural ecological environment of these species is still expected to be the gut from various (suckling) animals. In this environment such bifidobacterial taxa have enjoyed the presence of a rich reservoir of milk-based carbohydrates (oligosaccharides/lactose), which thus caused their genomes to acquire a genetic arsenal that allowed them to access these carbon sources. In contrast, B. ruminantium and B. boum taxa have been isolated from the bovine rumen (Table S1), an environment rich in plant polysaccharides, although they lack GH43-encoding genes and consequently cluster in GHP/B. Other rumen-derived bifidobacteria do encode GH43 enzymes, perhaps indicating that certain bifidobacteria rely on cross-feeding, which is in line with bifidobacteria being a minor component of the rumen microbiota, although their functional role is largely unknown. B. breve deserves a special mention as this species seems to have adopted a non-specialist strategy of acquiring constituent elements of both plant- and host-derived carbohydrates (consistent with its isolation from both infants and adults), yet is lacking the ability to directly access (many) HMOs, or mucin, nor possessing the ability to metabolize xylose/arabinose-containing carbohydrates, though it can metabolize a wide range of α/β-glucose- and α/β-galactose-containing sugars14,20. Thus, it may, perhaps co-operatively, rely on other (bifido)bacterial species like B. bifidum or B. longum subsp. infantis in order to sustain growth on the above mentioned complex sugars29.

Carbohydrate utilization patterns of Bifidobacterium

Fermentation profiles of the 47 sequenced Bifidobacterium strains revealed that all strains are able to ferment a common set of sugars, which include glucose, sucrose and raffinose (Fig. S5, panel a). In contrast, fermentation capabilities for other sugars, such as lactose, galactose, maltose, melibiose, fructose, lactulose, maltodextrins, turanose, β-gentibiose and xylose, were shown to be variable for the majority of the strains tested (Fig. S5, panel a). Notably, we identified bifidobacterial taxa such as B. cuniculi displaying an ability to grow on a wide range of simple and complex carbohydrates (Fig. S5, panel a), thus suggesting metabolic expansion of its carbohydrate acquisition abilities perhaps to enhance competitiveness in one or more ecological niches. In contrast, other bifidobacterial species, such as Bifidobacterium animalis subsp. animalis, only utilize a relatively small number of the carbohydrates assayed here (Fig. S5, panel a), an observation which, together with the very limited number of predicted GHs/carbohydrate pathways encoded by this taxon (Fig. 1), underlines a rather high level of genetic adaptation to an ecological niche. Growth studies highlighted the existence of different carbon sources that are differentially utilized by bifidobacteria, in a manner consistent with our predictions. In this context growth experiments involving most members of the B. asteroides phylogenetic group showed that they do not exhibit any appreciable growth on glycogen, an observation which is consistent with in silico pathway predictions. Cultivation trials performed on plant-derived carbohydrates such as arabinose or xylose revealed that these sugars are utilized by a majority of the bifidobacteria tested except for those taxa that form the GHP/B cluster (Fig. 1), which are not predicted to encode enzymes of the L-arabinose degradation I and xylose degradation I pathways. The ubiquitous monosaccharide mannose that is found in both plant and animal glycans, is easily shunted into the glycolytic pathway via isomerization of mannose-6-phosphate to fructose-6-phosphate30. Growth on mannose is, however, not a wide-spread property among the tested bifidobacterial taxa, a finding that is consistent with genomic data (Fig. 1), which revealed a variable distribution of genes supporting bifidobacterial mannose utilization such as genes encoding predicted mannosidases and mannose-6-phosphate isomerases. Interestingly, when mannosidase-encoding genes were detected, they were in the large majority of cases shown to be located within a putative N-glycan (host-derived) degradation cluster. Lactose constitutes a typical glycan that specifically occurs in the mammalian diet, though normally limited to the early stages of life31. In silico analyses involving the genomes of 47 bifidobacterial taxa revealed a ubiquitous distribution in their chromosomes of genes encoding β-galactosidases. This finding suggests a rather wide-spread utilization of lactose as well as other galactose-containing glycans such as galactan, galacto-oligosaccharides, Human milk oligosaccharides (HMO) and mucin, which require particular β-galactosidases for their degradation, among members of the Bifidobacterium genus20,32. Growth experiments involving lactose showed that, except for B. ruminantium and B. thermacidophilum subsp. thermacidophilum, all other tested bifidobacteria are able to ferment this disaccharide. In contrast, in silico analyses suggested that L-rhamnose is rarely used by bifidobacteria due to the apparent lack of genes encoding L-rhamno-gamma-lactonase, L-rhamnoate dehydratase and 2-keto-3-deoxy-L-rhamnoate aldolase. Notably, fermentation profiles involving this carbon source confirmed that only B. biavatii is able to ferment L-rhamnose. Furthermore, we evaluated the abilities of members of the genus Bifidobacterium to utilize typical host glycans like mucin and HMO. Interestingly, in addition to the currently known bifidobacterial archetypes that can utilize these host-glycans (B. bifidum and B. longum subsp. infantis)20,33, we identified that B. biavatii, B. crudilactis, B. kashiwanohense, Bifidobacterium stellenboschense and Bifidobacterium mongoliense are all capable of HMO metabolism. Inspection of their genome sequences revealed the presence of genes predicted to encode sialidases, fucosidases, N-acetyl-β-hexosaminidases, endo-α-N-acetylgalactosaminidase and β-galactosidases, which have previously been shown to be crucial for the breakdown of these complex carbohydrates20,33. This further illustrates the broad catabolic abilities of bifidobacteria in general and in particular their specialization to utilize complex carbohydrates that are commonly found in the (infant) mammalian GIT.

In order to substantiate the notion that bifidobacterial genomes contain specific genes responsible for the utilization of key carbohydrates that are present in their ecological niches and correspond to their saccharolytic phenotype, we investigated the transcriptome for a representative bifidobacterial species for each of the seven bifidobacterial phylogenetic clusters described previously10 grown on (where possible) glucose, glycogen, lactose, xylose, rhamnose, mannose, trehalose or HMO as the sole carbon source (Fig. S5, panel b). RNAseq experiments allowed the identification of the transcriptomes for each bifidobacterial strain tested in cases where growth was obtained, revealing that the carbohydrate metabolism COG family [COG category (G)], is one of the most represented in the transcriptomes (Fig. S5, panel c). Manual inspection of the identified transcriptomes highlighted the existence of a large arsenal of genes encoding GHs and other enzymes that constitute parts of carbohydrate metabolic pathways, including suspected carbohydrate carrier systems that are expressed when bifidobacteria are cultivated on a carbohydrate (Fig. S6). In this context, we identified β-galactosidases of the GH2 and GH42 families that were shown to be expressed when bifidobacteria are grown on lactose, as well as MFS and ABC systems predicted to act as carriers for lactose and/or glucose and/or galactose (Fig. S6). Cultivation of bifidobacteria on mannose, rhamnose, trehalose or xylose resulted, in cases where growth was observed, in the transcription of genes encoding specific catabolic pathways such as D-mannose degradation, L-rhamnose degradation II, trehalose degradation I and xylose degradation I (Fig. S6), observations that are consistent with our in silico assignments. The transcriptomes of bifidobacteria grown on glycogen clearly showed that transcription of genes encompassing the glycogen degradation I pathway, predicted to be indispensable for glycogen to glucose breakdown, is switched on under these circumstances (Fig. S6). The only exceptions are represented by the transcriptomes of Bifidobacterium pseudocatenulatum and B. stellenboschense in which the genes predicted to specify amylomaltase and glucokinase enzymes are not expressed, suggesting the existence of an alternative pathway for conversion of the intermediate carbohydrate maltose into β-D-glucose-6-phosphate. Transcriptomic data recovered from growth of B. biavatii on the complex substrate HMO revealed up-regulation of a sizable number of different GH-encoding genes, such as those predicted to belong to GH1 (predicted β-D-fucosidases), GH2 (putative β-galactosidases), GH3 (putative β-N-acetylhexosaminidases), GH29 (α-L-fucosidases), GH30 (possible β-fucosidases), GH36 (likely α-N-acetylgalactosaminidases), GH42 (putative β-galactosidases), GH85 (endo-β-N-acetylglucosaminidases) and GH112 (predicted galacto-N-biose/lacto-N-biose phosphorylases) (Fig. S6). Other up-regulated GH-coding genes included those specifying members of GH13, GH32 and GH43 families, even though their predicted enzymatic activities do not appear to be directed against HMO.

Mutualistic/commensal breakdown activities of bifidobacteria on carbohydrates

In gut ecosystems, bacteria can exploit mutualistic as well as commensal and competitive activities during metabolism of various carbon sources available in such an environment. Thus, we were interested to evaluate possible trophic relationships towards carbohydrates between bifidobacterial taxa found in various ecological niches. Specific bi-association of bifidobacterial taxa were selected based on their common ecological origin (e.g., human-, porcine-, or rabbit-gut). Their growth performances on carbon sources that are commonly available in their particular ecological niche were assayed during co-cultivation (bi-association) and compared to those achieved when the strains were grown separately (mono-association). Such trials suggested that when cultivated together these bifidobacterial taxa were taking an evident benefit as supported by the enhanced cell densities in the bi-associations compared to the mono-associations (Fig. 3). These growth-benefits were in a few cases evident for both strains such as in the case of the B. magnum and B. cuniculi combination when these strains were cultivated on xylan or on starch (Fig. 3). Such findings were further supported by the evaluation of transcriptomic changes, employing an RNAseq approach, observed for these bifidobacterial strains when cultivated together as compared to the situation where these strains were assayed separately. Notably, in bi-associations where a benefit was noticed in terms of cell numbers for both strains, such as for B. magnum and B. cuniculi cultivated on starch, complementarity in terms of the transcription of the genetic repertoire for the metabolism of this complex sugar was observed for these strains. In fact, under such conditions the alpha-glucoside phosphorylase-specifying genes, i.e. BMAGN_0016 and BCUN_1467, as well as amylase-encoding genes, i.e. BMAGN_0612 and BCUN_0313, of both B. magnum and B. cuniculi were shown to be transcribed (Fig. 3). Interestingly, while these latter enzymes are predicted to be intracellular, two genes encoding putative extracellular pullulanases (BCUN_0354 and BCUN_0356), were shown to be transcribed. Even though the detected transcription level for these genes was low, it may be that such enzymes allowed a partial de-branching of starch so as to allow internalization of the released degradation products into the bacterial cell for complete degradation. The resulting starch-degradation products such as maltose and alpha-glucosides are presumed to be internalized by means of ABC transporters (BMAGN_0006-BMAGN_0009 and BCUN_2019-BCUN_2022) and/or PTS systems (BMAGN_0338 and BCUN_1552), of which the corresponding genes were shown to exhibit increased transcription (2.37 fold and 10.42 fold with p < 0.001, respectively) relative to mono-association conditions (Fig. 3). Thus, on this substrate both strains appear to co-operate in order to achieve starch degradation thanks to the collective action of their extracellular amylases, perhaps resulting in the production of a larger amount of starch-derivatives compared to that achieved when the strains are cultivated separately on this substrate. In contrast, when these strains were co-cultivated on xylan, we only noticed an up-regulation of the gene encoding a beta-xylosidase (BCUN_1638) in B. cuniculi. Similarly, B. cuniculi exhibited a modest transcriptional upregulation of the genes specifying the putative uptake and degradation machinery for xylose (BCUN_0705-BCUN_0707 and BCUN_1645), whereas B. magnum showed no modulation in the beta-xylosidase-encoding gene, yet down-regulation of genes involved in xylose transport. The latter findings suggest that B. magnum modulates gene expression in order to support growth of B. cuniculi and allows this latter strain to participate in xylan degradation and harvesting of the deriving xylose. Since none of these enzymes are predicted to be extracellular, an alternative explanation for this behavior is partial degradation of xylan to xylo-oligosaccharides during media preparation. These degradation products can be the target for specific uptake transporters, allowing their complete breakdown inside the bacterial cells. Another scenario was noticed for the co-cultivation of B. stellenboschense and B. biavatii grown in the presence of glycogen, where only the latter strain seems to take advantage of the presence of the other strain (Fig. 3). In fact, under these circumstances B. biavatii substantially enhanced transcription of various genes encoding enzymes predicted to be involved in the hydrolysis of glycogen such as predicted glycosyl hydrolases of the GH13 and GH77 families, as well as a glycogen phosphorylase (Fig. 3). In contrast, B. stellenboschense did not reveal any transcriptional modulation of genes with predicted functions in glycogen utilization when the strains were co-cultivated (Fig. 3). Similarly, data concerning co-cultivation of B. longum subsp. suis and B. thermacidophilum subsp. porcinum on starch is also consistent with a cross-feeding scenario. In fact, under these growth conditions, qPCR assays revealed that cell numbers of B. longum subsp. suis are enhanced (≥2 fold) with respect to those noticed when this strain was cultivated on its own on this substrate. Furthermore, transcriptome analyses revealed a significant induction (≥8 fold, p < 0.001) of genes encoding a complete ABC system involved in the up-take of maltose, which is a starch-derived glycan, of B. longum subsp. suis when grown with B. thermacidophilum subsp. porcinum in the presence of starch as the sole carbon source (Fig. 3). In contrast, even though the B. thermacidophilum subsp. porcinum genome is predicted to encode a secreted GH13 family enzyme (BPORC_0608), the transcription of genes predicted to be involved in starch metabolism of B. thermacidophilum subsp. porcinum did not appear to be affected by the presence of B. longum subsp. suis (Fig. 3).

Figure 3: Evaluation of possible bifidobacterial cross-feeding by a transcriptomics approach.
Figure 3

(Panel a) reports the abundance, observed through quantitative qRT-PCR, of eight bifidobacterial species cultivated in MRS supplemented with four different carbohydrates. These species were either grown on their own (mono-association) or in the presence of another bifidobacterial strain (bi-associations) sharing the same ecological niche. The five case studies analysed are named progressively with letters from A to D, corresponding to: B. cuniculi and B. magnum grown on starch (A), B. cuniculi and B. magnum grown on xylan (B), B. biavatiiand B. stellenboschense grown on glycogen (C) and B. thermacidophilum subsp. porcinum and B. longumsubsp. suis grown on starch (D). (Panel b) shows the transcriptional fold change of genes encoding enzymes in the breakdown of glycans observed in the five case studies, named progressively with letters from A to D. Functional annotation of enzymes are indicated in orange while the functional annotation of transporter encoding genes and the predicted glycan specificity is highlighted in green.

Overall, our findings suggest that bifidobacteria access carbohydrates that are commonly present in their ecologic niches employing trophic interactions that may vary from commensalism to mutualistic. Furthermore, these concerted breakdown activities may similarly exert positive effects on other members of the gut microbiota and thus promote an expansion of the gut glycobiome.

Bifidobacteria and mammalian gut adaptation

Bifidobacteria have predominantly been identified in the GIT of mammals1. However, their functional contribution to the microbiota residing in this body compartment has not been thoroughly investigated. We therefore looked for the presence of GH-encoding bifidobacterial DNA sequences among 44 out of 136 available gut metagenome data sets from healthy adults, enrolled in the Human Microbiome Project19 that had shown consistent presence of bifidobacteria based on MetaPhlAn profiling34, as well as in nine metagenomes and related metatranscriptomes of healthy infant gut microbiota, sequenced by the Broad Institute (NCBI bioproject ID 63661). The coverage of each gene included in the bifidobacterial pangenome was computed based on the metagenomic reads with >98% full-length identity. As displayed in Fig. 4, the average abundance of Bifidobacterium genes ranged from 0.2% to 35.9%, with a distinctly higher prevalence of bifidobacteria in the faecal metagenomes from infants. This is consistent with the catabolic potential for HMOs. Interestingly, among the most frequently represented bifidobacterial genes in the metagenomic data sets from adult, the presence of an extensive repertoire of GH-encoding genes, such as those specifying GH3, GH13, GH43, GH51 and GH77 (involved in the breakdown of complex plant carbohydrates), is noteworthy (Fig. 4). Such findings reinforce the notion that despite the relative paucity of bifidobacteria detected in the adult human gut, their functional contribution to the human gut microbiome may be important in terms of expanding the overall glycobiome of the large intestine, thereby affecting the overall gut physiology. Furthermore, in the metagenome datasets from infants the relatively high bifidobacterial abundance is also reflected by the prevalence of bifidobacterial GH-encoding genes, such as those specifying members of the GH2, GH20, GH29, GH33, GH36, GH42, GH84, GH95, GH101 and GH112 families, involved in the degradation of milk-related carbohydrates such as lactose and HMOs, as well as in mucin degradation (Fig. 4). Notably, GH-specifying genes encoding β-hexosaminidases, lacto-N-biosidases, galacto-N-biose/lacto-N-biose phosphorylases, α-L-fucosidases, sialidases, neuraminidases, N-acetyl β-glucosaminidases, hyaluronidases and endo-α-N-acetylgalactosaminidases are not widespread in adult metagenomes (Fig. 4). Availability of metatranscriptomes corresponding to the analysed infants’ metagenomes revealed pronounced transcription of the bifidobacterial GH gene predicted to be involved in milk, HMO and mucin degradation (Fig. 4), clearly supporting the key functional roles exploited by these GHs in the infant gut microbiota.

Figure 4: Data mining for bifidobacterial GH genes and bifidobacterial pathways for carbohydrate degradation in adult and infant fecal metagenome data sets and an infant fecal metatranscriptome data set.
Figure 4

Bar plots above the heatmaps show the relative abundance of bifidobacteria in the analysed samples. Heatmaps in the upper part depict the coverage obtained by alignment of adult and infant fecal metagenomic data sets, or infant metatranscriptome data sets to predicted bifidobacterial GH-encoding genes. In order to compare results for datasets with different sizes, all coverage values were normalized as obtained from a 10 million read dataset. Heatmaps in the lower part of the image represent the coverage obtained by alignment of the same datasets to genes constituting the bifidobacterial pathways for carbohydrate degradation. Relevant GH genes and pathways involved in the metabolism of glycans are highlighted in red. Pathways designations are identical to those indicated in Fig. 1.

To further elucidate the functional contribution of bifidobacteria to the human microbiota we screened the metagenomic and metatranscriptomic datasets for the presence of genes encompassing carbohydrate degradation pathways that had been predicted to be present in the bifidobacterial pan-genome (Figs 1 and 4). Both the adult and infant metagenomes showed a high abundance of genes for the Bifidobacterium phosphoketolase-dependent, or so-called bif shunt, pathway, as expected, as well as genes involved in galactose degradation I, melibiose degradation, lactose degradation III, glycogen degradation I, glycogen degradation II and sucrose degradation IV pathways (Fig. 4), accompanied by presence of genes involved in starch degradation V, arabinose degradation I, xylan degradation and xylose degradation I pathways. The presence of such pathways illustrates their presumed importance for adaptation of bifidobacteria to the human gut environment. Interestingly, the infant’s metatranscriptomic datasets correspond to the presence of the bif shunt (as expected) and pathways for galactose, lactose, glycogen and sucrose degradation, while no or low transcriptional activity was detected that corresponded to catalytic pathways for the plant polysaccharides arabinose, xylan and xylose (Fig. 4), reflecting the paucity of these carbohydrates in an infant’s diet.

Conclusions

Bifidobacteria may be considered as key representatives of the mammalian gut microbiota, especially during the first phase of their host’s life. However, very little is known about their genetic strategies to colonize and persist within the gut, and to get access to the nutrients available in this environment. The current study highlights the very extensive saccharolytic features displayed by members of the Bifidobacterium genus, revealing how these bacteria metabolize specific carbohydrates available in their particular ecological niche. Comparison of the glycobiome identified in the genus Bifidobacterium with those identified in other members of the human gut microbiota revealed their unique and important contribution in terms of GHs involved in the breakdown of complex plant carbohydrates such as arabinoxylan, galactan and starch. The impact of bifidobacteria in the breakdown of dietary carbohydrates is also crucial for the establishment and reinforcement of trophic relationships between members of the gut microbiota. In fact, both mutualistic as well as commensal interactions in the mammalian gut can be carbohydrate-driven6,7. Here, we have shown how a simple bifidobacterial community may co-operate between themselves as well as with other members of the gut microbiota in the utilization of specific glycans, commonly available in the mammalian gut, by means of cross-feeding activities so as to provide growth benefits to one or both members of such a community as well as with the other members of the gut microbiota. Such findings support the concept of the existence of a social intelligence of bifidobacterial communities in the harvesting and metabolism of glycans available in their ecological niches, which regulate the dynamics of the gut microbiota relationships. However, it is reasonable to expect that in much more complex microbial communities such as those identified in the mammalian gut, cross-feeding activities as exemplified by bifidobacteria also involve other members of the gut microbiota, perhaps generating an even larger beneficial effect. A survey of human gut metagenomic datasets, representing both adult and infant samples, revealed that, notwithstanding their relatively low abundance in adults, the functional contribution of bifidobacteria to the enzymatic arsenal directed at degradation of complex carbohydrates is relevant. In this context, the expansion of the GH repertoire dedicated to the metabolism of infant dietary sugars, such as HMOs, as well as mucin is noteworthy. Another clear sign of advanced bifidobacterial adaptation to its mammalian host is represented by the identification in a small number of bifidobacterial taxa which include B. bifidum, B. longum subsp. infantis20,33, as well as B. biavatii, B. crudilactis, B. kashiwanohense, B. stellenboschense and B. mongoliense, of metabolic repertoires involved in the breakdown of host-derived glycans such as HMOs and mucin.

Materials and Methods

Bacterial strains, growth conditions

All Bifidobacterium strains were cultivated in an anaerobic atmosphere (2.99% H2, 17.01% CO2 and 80% N2) in a chamber (Concept 400, Ruskin) on De Man-Rogosa-Sharp (MRS) broth (Scharlau Chemie, Barcelona, Spain) supplemented with 0.05% (w/v) L-cysteine hydrochloride and incubated at 37 °C. Cell growth on semi synthetic MRS medium supplemented with 1% (wt/vol) of a particular sugar was monitored by optical density at 600 nm using a plate reader (Biotek, Vermont, USA). The plate reader was run in discontinuous mode, with absorbance readings performed in 60 min intervals, and preceded by 30 sec shaking at medium speed. Cultures were grown in biologically independent triplicates and the resulting growth data were expressed as the mean of these replicates. Carbohydrates were purchased from Sigma (Milan, Italy) or Carbosynth (Berkshire, UK). All the carbohydrates were dissolved in water and then sterilized by filtration using 0.2 micron filter size and then added to autoclaved MRS with the exception of xylan (Poly(β-D-xylopyranose[1→4]) (Sigma, Aldrich) which was autoclaved with MRS.

In the case of HMO experiments, human milk samples were kindly provided by the Western Thrust Human Milk Bank (Irvinestown, Co. Fermanagh, Ireland). The isolation of oligosaccharides from pooled samples (n ≥ 3) was performed as described previously35. Briefly, samples were defatted by centrifugation at 4 °C (3850 × g, 20 min, Sorvall RC6 plus®). Caseins were precipitated at pH 4.6. After neutralization, large peptides were removed by ultrafiltration (5 kDa molecular-weight cut-off, Millipore® Helicon S10 Spiral Cartridge). The permeates were freeze-dried and stored at −80 °C until further processing. To remove lactose and residual peptides, the extracts were re-solubilized in MilliQ® water and applied to a Sephadex G-25 column (Pharmacia, Uppsala, Sweden; 92 × 2.6 cm). Elution was performed with deionized water (5 mL/min). Fractions were monitored for peptides according to Bradford36 and the lactose content was determined by HPAEC35. Fractions low in peptide- and lactose content were pooled and used for further characterization.

Bifidobacterial and hosts phylogenetic reconstruction

The phylogeny of the 47 was reconstructed as described previously9,10. Phylogeny of the eukaryotic hosts was reconstructed through the SUPERFAMILY web tool37.

Bifidobacterial transcriptomics identification through RNAseq assays

B. biavatii, B. boum, B. stellenboschense, B. coryneforme, B. cuniculi, B. gallinarum and B. pseudocatenulatum were selected as representatives for each of the seven phylogenetic groups. These strains were grown in MRS supplemented with glucose, glycogen, lactose, xylose, rhamnose, mannose, trehalose or HMO as a carbon source. In order to evaluate cross-feeding activities between two bifidobacterial strains, bacteria were co-cultivated on MRS supplemented with a particular glycan [RS2-resistant starch (Sigma, Aldrich), xylan (Poly(β-D-xylopyranose[1→4]) (Sigma, Aldrich) or glycogen (Sigma, Aldrich)], and growth was monitored by the evaluation of optical density at 600 nm followed by qRT-PCR using strain-specific primers (see below).

When growth was observed during logarithmic phase, cell pellets were resuspended in 1 ml of QUIAZOL (Quiagen, UK) and placed in a tube containing 0.8 g of glass beads (diameter, 106 μm; Sigma). The cells were lysed by shaking the mix on a BioSpec homogenizer at 4 °C for 2 min (maximum setting). The mixture was then centrifuged at 12,000 rpm for 15 min, and the upper phase containing the RNA-containing sample was recovered. The RNA sample was further purified by phenol extraction and ethanol precipitation according to an established method38. Quality and integrity of the RNA was checked by Agilent 2200 Tape Station Nucleic Acid System (Agilent Technologies, Palo Alto, Calif.). One hundred ng of total RNA was used as the starting input for RNA-Seq library preparation. Briefly, 100 ng of total RNA was treated with Ribo-Zero rRNA removal kit for Gram-positive bacteria (Epicentre, Madison, WI, U.S.A.) to remove rRNA according to the supplier’s instructions. The yield of rRNA depletion was checked by Agilent 2200 Tape Station Nucleic Acid System (Agilent Technologies, Palo Alto, Calif.). Then, rRNA-depleted RNA samples were fragmented using RNaseIII (Life Technologies, USA) followed by size evaluation using Experion (BioRad, UK). Whole transcriptome library was constructed using the Ion Total-RNA Seq Kit v2 (Life Technologies, USA). Barcoded libraries were quantified by qRT-PCR and each library template was amplified on Ion Sphere Particles using Ion One Touch 200 Template Kit v2 (Life Technologies, USA). Samples were loaded into 316 Chips and sequenced on the PGM (Life Technologies, USA). Sequencing reads were depleted of adapters, quality filtered (with overall quality, quality window and length filters) with FastqMcf ( https://code.google.com/p/ea-utils/) and aligned to the respective bifidobacterial reference genome through BWA39 with high stringency cut-offs (99% nucleotide identity) in order to accurately map reads of co-cultivation datasets on the correct genome. Counts of reads overlapping ORFs were performed using HTSeq ( http://www-huber.embl.de/users/anders/HTSeq/doc/overview.html) and analysis of the count data was performed using the R package DESeq240. When the RNAseq analyses of mono-associations, DESeq2 output consists of fold induction values determined as the normalized number of transcripts identified for a given gene for bacterial cells cultivated on MRS containing a specific carbohydrate, relative to the number of identified transcripts for that same gene when the strain was grown on MRS containing glucose (reference condition). In case of RNAseq analysis of bi-associations, DESeq2 output consists of fold-induction values determined as the normalized number of transcripts identified for a given gene for bacterial cells cultivated in mono-association relative to the normalized number of identified transcripts for that same gene when the strain was cultivated in bi-association, using MRS supplemented with the same carbohydrate for both conditions. DESeq2 data normalization and differential gene expression analysis are based on the negative binomial distribution, which takes into consideration the overall transcript abundance identified for each analysed sample40.

Evaluation of the cell density by qPCR

The co-cultivation with other bacteria was monitored by quantitative PCR (qPCR). The copy-number of a gene for a given strain used in the co-cultivation experiments was evaluated and compared to the growth rate of each individually cultivated microorganism. qPCR was performed using the CFX96 system (BioRad, CA, USA). Primers used in this study are listed in Table S2. Each PCR reaction mix contained the following: 7.5 μl 2× SYBR SuperMix Green (BioRad, CA, USA), 5 μl of DNA dilution, each of the forward and reverse primers at 0.5 μM and nuclease-free water was added to obtain a final volume of 15 μl. PCR products were detected with SYBR Green fluorescent dye and amplified according to the following protocol: one cycle of 95 °C for 3 minutes, followed by 39 cycles of 95 °C for 5 s and 60 °C for 20 s. Melting curve: 65 °C to 95 °C with increments of 0.5 °C/s. In each run, negative controls (no DNA) for each primer set were included. Standard curve was built using the CFX96 software (BioRad).

Bifidobacterial gene survey of human gut metagenomic and metatranscriptomic datasets

We surveyed the presence of bifidobacterial genes into the microbial diversity of the healthy gut of 44 adults and nine infants. To this end we implemented a mapping-based pipeline to detect the presence and quantify the coverage of these gene categories annotated from the newly sequenced strains into the Illumina deep shotgun-sequenced metagenomic data sets derived from stool samples of the Human Microbiome Project (HMP)19 and into Illumina deep shotgun-sequenced metagenomic and metatranscriptomic data sets obtained from stool samples of nine healthy infants. The mapping was performed using BowTie241 using multiple-hit mapping and “very-sensitive” policy. The mapping was post-processed with a custom script to retain those matches with at least 98% full-length identity with respect to at least one reference gene by threshold-ing the BowTie2 score at −12 for the 100 nt-long adults and infant datasets (−6 is the penalty for a high-quality mismatch). Genes covered by matching reads for less than 90% of their full length were discarded and the final gene-wise average coverage was computed using SAMtools42 and BEDtools43. In the final matrices, GHs genes and genes constituting carbohydrate-degrading pathways were collapsed into GH families and MetaCyc pathways. The estimation of the relative abundance of bifidobacteria (at the genus level) was performed with MetaPhlAn34.

Data Deposition

The RNAseq data were deposited in SRA database under the following study accession numbers: PRJNA239567 and PRJNA277297.

Additional Information

How to cite this article: Milani, C. et al. Bifidobacteria exhibit social behavior through carbohydrate resource sharing in the gut. Sci. Rep. 5, 15782; doi: 10.1038/srep15782 (2015).

References

  1. 1.

    , , , & Host-microbe interactions that facilitate gut colonization by commensal bifidobacteria. Trends in microbiology 20, 467–476, doi: 10.1016/j.tim.2012.07.002 (2012).

  2. 2.

    , , & 1 online resource (2 v.) (Springer, New York, 2012).

  3. 3.

    et al. Diversity of Bifidobacteria within the Infant Gut Microbiota. PLoS One 7, e36957, doi: 10.1371/journal.pone.0036957 (2012).

  4. 4.

    et al. Assessing the fecal microbiota: an optimized ion torrent 16S rRNA gene-based analysis protocol. PLoS One 8, e68739, doi: 10.1371/journal.pone.0068739 (2013).

  5. 5.

    et al. Exploring the diversity of the bifidobacterial population in the human intestinal tract. Applied and environmental microbiology 75, 1534–1545, doi: 10.1128/AEM.02216-08 (2009).

  6. 6.

    , , , & The abundance and variety of carbohydrate-active enzymes in the human gut microbiota. Nat Rev Microbiol 11, 497–504, doi: 10.1038/nrmicro3050 (2013).

  7. 7.

    , & How glycan metabolism shapes the human gut microbiota. Nature reviews. Microbiology 10, 323–335, doi: 10.1038/nrmicro2746 (2012).

  8. 8.

    et al. Genome-scale analyses of health-promoting bacteria: probiogenomics. Nature reviews. Microbiology 7, 61–71, doi: 10.1038/nrmicro2047 (2009).

  9. 9.

    et al. Genomic encyclopedia of type strains of the genus Bifidobacterium. Applied and environmental microbiology 80, 6290–6302, doi: 10.1128/AEM.02308-14 (2014).

  10. 10.

    et al. Investigation of the evolutionary development of the genus Bifidobacterium by comparative genomics. Applied and environmental microbiology 80, 6383–6394, doi: 10.1128/AEM.02004-14 (2014).

  11. 11.

    et al. eggNOG v4.0: nested orthology inference across 3686 organisms. Nucleic acids research 42, D231–239, doi: 10.1093/nar/gkt1253 (2014).

  12. 12.

    , , , & Genomics as a means to understand bacterial phylogeny and ecological adaptation: the case of bifidobacteria. Antonie Van Leeuwenhoek 91, 351–372, doi: 10.1007/s10482-006-9122-6 (2007).

  13. 13.

    , , , & The carbohydrate-active enzymes database (CAZy) in 2013. Nucleic acids research 42, D490–495, doi: 10.1093/nar/gkt1178 (2014).

  14. 14.

    , & Carbohydrate metabolism in Bifidobacteria. Genes & nutrition 6, 285–306, doi: 10.1007/s12263-010-0206-6 (2011).

  15. 15.

    & Xylan biosynthesis. Current opinion in biotechnology 26C, 100–107, doi: 10.1016/j.copbio.2013.11.013 (2014).

  16. 16.

    , , & The effects of dietary fibre addition on the quality of common cereal products. Journal of Cereal Science 58, 216–227 (2013).

  17. 17.

    , , , & Saccharide breakdown and fermentation by the honey bee gut microbiome. Environmental microbiology 17, 796–815, doi: 10.1111/1462-2920.12526 (2015).

  18. 18.

    et al. Metagenomic analysis of the human distal gut microbiome. Science 312, 1355–1359, doi: 10.1126/science.1124234 (2006).

  19. 19.

    Human Microbiome Project, C. Structure, function and diversity of the healthy human microbiome. Nature 486, 207–214, doi: 10.1038/nature11234 (2012).

  20. 20.

    et al. Genome analysis of Bifidobacterium bifidum PRL2010 reveals metabolic pathways for host-derived glycan foraging. Proc Natl Acad Sci USA 107, 19514–19519, doi: 10.1073/pnas.1011100107 (2010).

  21. 21.

    et al. An exo-alpha-sialidase from bifidobacteria involved in the degradation of sialyloligosaccharides in human milk and intestinal glycoconjugates. Glycobiology 21, 437–447, doi: 10.1093/glycob/cwq175 (2011).

  22. 22.

    et al. Pathway Tools version 13.0: integrated software for pathway/genome informatics and systems biology. Briefings in bioinformatics 11, 40–79, doi: 10.1093/bib/bbp043 (2010).

  23. 23.

    & Glycogen with short average chain length enhances bacterial durability. Die Naturwissenschaften 98, 719–729, doi: 10.1007/s00114-011-0832-x (2011).

  24. 24.

    & Insights into glycogen metabolism in Lactobacillus acidophilus: impact on carbohydrate metabolism, stress tolerance and gut retention. Microbial cell factories 13, 94, doi: 10.1186/s12934-014-0094-3 (2014).

  25. 25.

    et al. Glycogen and maltose utilization by Escherichia coli O157:H7 in the mouse intestine. Infection and immunity 76, 2531–2540, doi: 10.1128/IAI.00096-08 (2008).

  26. 26.

    , & Glycogen metabolism loss: a common marker of parasitic behaviour in bacteria? Trends in genetics: TIG 18, 437–440 (2002).

  27. 27.

    et al. Phylogenomics resolves the timing and pattern of insect evolution. Science 346, 763–767, doi: 10.1126/science.1257570 (2014).

  28. 28.

    The Biochemistry of Sugars and Polysaccharides in Insects. Advances in Insect Physiology 4, 287–360 (1967).

  29. 29.

    et al. Cross-feeding by Bifidobacterium breve UCC2003 during co-cultivation with Bifidobacterium bifidum PRL2010 in a mucin-based medium. BMC microbiology 14, 282, doi: 10.1186/s12866-014-0282-7 (2014).

  30. 30.

    , & Genomic and metabolic studies of the impact of probiotics on a model gut symbiont and host. PLoS Biol 4, e413, doi: 10.1371/journal.pbio.0040413 (2006).

  31. 31.

    & Human milk and related oligosaccharides as prebiotics. Current opinion in biotechnology 24, 214–219, doi: 10.1016/j.copbio.2013.01.008 (2013).

  32. 32.

    Bifidobacterial enzymes involved in the metabolism of human milk oligosaccharides. Advances in nutrition 3, 422S–429S, doi: 10.3945/an.111.001420 (2012).

  33. 33.

    et al. The genome sequence of Bifidobacterium longum subsp. infantis reveals adaptations for milk utilization within the infant microbiome. Proceedings of the National Academy of Sciences of the United States of America 105, 18964–18969, doi: 10.1073/pnas.0809584105 (2008).

  34. 34.

    et al. Metagenomic microbial community profiling using unique clade-specific marker genes. Nature methods 9, 811–814, doi: 10.1038/nmeth.2066 (2012).

  35. 35.

    et al. Method for milk oligosaccharide profiling by 2-aminobenzamide labeling and hydrophilic interaction chromatography. Glycobiology 21, 1317–1330, doi: 10.1093/glycob/cwr067 (2011).

  36. 36.

    A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical biochemistry 72, 248–254 (1976).

  37. 37.

    et al. SUPERFAMILY–sophisticated comparative genomics, data mining, visualization and phylogeny. Nucleic acids research 37, D380–386, doi: 10.1093/nar/gkn762 (2009).

  38. 38.

    , & Molecular cloning: a laboratory manual. Cold Spring Harbor,NY: Cold Spring Harbor Laboratory, 545 (1989).

  39. 39.

    & Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754–1760, doi: 10.1093/bioinformatics/btp324 (2009).

  40. 40.

    , & Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome biology 15, 550, doi: 10.1186/s13059-014-0550-8 (2014).

  41. 41.

    & Fast gapped-read alignment with Bowtie 2. Nature methods 9, 357–U354, doi: 10.1038/Nmeth.1923 (2012).

  42. 42.

    et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078–2079, doi: 10.1093/bioinformatics/btp352 (2009).

  43. 43.

    & BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841–842, doi: 10.1093/bioinformatics/btq033 (2010).

Download references

Acknowledgements

We thank GenProbio srl for financial support of the Laboratory of Probiogenomics. This work was financially supported by a FEMS Jensen Award to FT, and by a Ph.D. fellowship (Spinner 2013, Regione Emilia Romagna) to S.D. DvS and FT are members of The APC Microbiome Institute, while DvS is also a member of the Alimentary Glycoscience Research Cluster, both funded by Science Foundation Ireland (SFI), through the Irish Government’s National Development Plan (Grant numbers SFI/12/RC/2273 and 08/SRC/B1393, respectively). This work was also partially supported by Fondazione Caritro, by the EU FP7 (PCIG13- GA-2013-618833), and by MIUR “Futuro in Ricerca” E68C13000500001 to NS. Furthermore, this project has been funded in part with funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN272200900018C.

Author information

Author notes

    • Borja Sanchez

    Present address: Department of Analytical Chemistry and Food Science, Faculty of Food Science and Technology, University of Vigo, Spain.

Affiliations

  1. Laboratory of Probiogenomics, Department of Life Sciences, University of Parma, Italy

    • Christian Milani
    • , Gabriele Andrea Lugli
    • , Sabrina Duranti
    • , Leonardo Mancabelli
    • , Chiara Ferrario
    • , Marta Mangifesta
    • , Alice Viappiani
    • , Stefania Arioli
    •  & Marco Ventura
  2. APC Microbiome Institute and School of Microbiology, Bioscience Institute, National University of Ireland, Cork, Ireland

    • Francesca Turroni
    •  & Douwe van Sinderen
  3. Departamento de Microbiologia y Bioquimica de Productos Lacteos, IPLA – CSIC, Villaviciosa, Asturias, Spain

    • Arancha Hevia
    • , Borja Sanchez
    •  & Abelardo Margolles
  4. Centre for Integrative Biology, University of Trento, Trento, Italy

    • Matthias Scholz
    •  & Nicola Segata
  5. Teagasc Food Research Centre, Moorepark, Cork, Ireland

    • Jonathan Lane
    •  & Rita Hickey
  6. Broad Institute, 415 Main St., Cambridge, USA

    • Doyle V. Ward
  7. Department of Food Environmental and Nutritional Sciences, University of Milan, Italy

    • Diego Mora

Authors

  1. Search for Christian Milani in:

  2. Search for Gabriele Andrea Lugli in:

  3. Search for Sabrina Duranti in:

  4. Search for Francesca Turroni in:

  5. Search for Leonardo Mancabelli in:

  6. Search for Chiara Ferrario in:

  7. Search for Marta Mangifesta in:

  8. Search for Arancha Hevia in:

  9. Search for Alice Viappiani in:

  10. Search for Matthias Scholz in:

  11. Search for Stefania Arioli in:

  12. Search for Borja Sanchez in:

  13. Search for Jonathan Lane in:

  14. Search for Doyle V. Ward in:

  15. Search for Rita Hickey in:

  16. Search for Diego Mora in:

  17. Search for Nicola Segata in:

  18. Search for Abelardo Margolles in:

  19. Search for Douwe van Sinderen in:

  20. Search for Marco Ventura in:

Contributions

C.M. designed all of the experiments, performed bionformatics analyses as well as pathways predictions and wrote the manuscript. G.A.L. and L.M. performed genomics and comparative genomics bioinformatic analyses. N.S., D.V.W. and M.S. were involved in screening of metagenomics datasets. S.D., F.T., C.F., M.M. and A.V. performed all the experiments involving RnaSeq sequencing while A.H., S.A., B.S., J.L., R.H. and D.M. were involved in growth of bifidobacterial strains on different substrates. M.V., A.M. and D.V.S. conceived the study, revised and approved the manuscript. All authors reviewed the manuscript.

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to Marco Ventura.

Supplementary information

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Creative Commons BYThis work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/